Canada Clinical Nutrition - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
The Canada Clinical Nutrition Market size is estimated at USD 1.71 billion in 2024, and is expected to reach USD 2.29 billion by 2029, growing at a CAGR of 6.07% during the forecast period (2024-2029).
The key factors responsible for the market growth include the growing burden of chronic and metabolic diseases, rising cases of diabetes, and the rising geriatric population in the country.
The chronic diseases put a significant burden on Canada's healthcare system. For instance, as per the data published in February 2022 by the Heart and Stroke Foundation Canada, around 750,000 people were living with heart failure, and 100,000 people were diagnosed with this incurable condition each year, which is further expected to increase with the rising aging population and cardiovascular risk factors such as hypertension and smoking, among others. Therefore, there is a growing need for better dietary inclusions in the lives of Canadian people, which is expected to boost the demand for clinical nutrition products in the coming years.
Furthermore, metabolic diseases are one of the key applications of clinical nutrition products. The increasing incidence of diseases such as diabetes in compliance with the rising investment from the Canadian government for diabetes research and development is propelling the growth of the studied market in the country. For instance, as per the Diabetes Canada Report published in February 2022, over 5,719,000 people were suffering from Diabetes in Canada as of 2022, which is expected to reach 7,277,000 by the year 2032. To cope with the rising burden of diabetes, people are inclining more toward dietary changes and adopting clinical nutrition, which is a beneficial factor for the market studied.
Canada's rapidly aging population presents a significant opportunity for the clinical nutrition market. For instance, the Toronto Star newspaper published in February 2023 stated that 1 in 4 Canadians will be older than 65 by 2035. Additionally, seniors account for almost 445 of provincial and territorial healthcare budgets, and unpaid care provision costs Canada an estimated USD 1.3 billion in productivity losses each year. Thus, as the demand for senior care rises, the need for specialized nutritional products and services to address the unique needs of the elderly will continue to grow in the market in the forecast period.
Hence, owing to the above-mentioned factors, such as the growing burden of chronic and metabolic diseases, the growing cases of diabetics, and the rising older population in the country, the market studied is believed to witness significant growth during the forecast period.
However, stringent regulatory policies are expected to hinder market growth in the long run.
Canada Clinical Nutrition Market Trends
Malnutrition is Expected to Hold a Major Share in the Coming Years
Malnutrition is one of the biggest challenges that Canada faces in some territories. The presence of organizations such as the Canadian Malnutrition Task Force (CMTF) in the country significantly benefits the clinical nutrition market as these organizations help the general population understand the significance of nutrition in daily life.
The number of people with malnutrition is rising in the country, which is propelling the demand for clinical nutrition. For instance, as per the data from Statistics Canada published in February 2023, it was indicated that over 6.9 million people in around ten provinces of Canada lived in food-insecured households, which included over 1.8 million children. The Canadian government is providing funds to cope with the rising food insecurity, which results in malnutrition. For instance, in May 2023, the Canadian government announced funding of USD 84.6 million to fight against malnutrition in Canada and globally.
Canada's regulatory authorities are focusing on funding several clinics to develop personalized nutrition products. For instance, in January 2022, the National Institutes of Health (NIH) provided funding of USD 170 million. They announced that it would be utilized nationwide for the next five years in clinics and centers. The funding was majorly provided for a new study to predict individual responses to food and dietary routines. Therefore, with such funding for nutrition improvement across the country, the segment is expected to witness significant growth during the study period.
Pediatric Clinical Nutrition is Expected to Witness a Strong Growth in Coming Years
The pediatric nutrition segment of the market studied is expected to grow due to factors such as growing pre-term births and companies' rising focus on launching new products in the market.
The companies operating in Canada are implementing various growth strategies, including acquisitions, new product launches, and partnerships, to expand their product portfolio and geographical presence in the market. For instance, in February 2022, Nestle Health Science signed an acquisition of Orgain Company, a plant-based nutrition product company. With the help of this acquisition, Nestle expanded the reach of plant-based nutrition products. Hence, companies' initiatives to launch products in the Canadian market are expected to grow significantly during the forecast period.
Canada Clinical Nutrition Industry Overview
The market for clinical nutrition in Canada is moderately competitive and fragmented in nature. The market players are continuously engaged in expanding their presence through various inorganic growth strategies, such as acquisition, merger, and strategic collaboration, to gain significant market share and strengthen their product portfolios. Some of the key players in the market include Abbott Laboratories, Nestle SA, Baxter Healthcare, B. Braun SE, and Danone, among others.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
The key factors responsible for the market growth include the growing burden of chronic and metabolic diseases, rising cases of diabetes, and the rising geriatric population in the country.
The chronic diseases put a significant burden on Canada's healthcare system. For instance, as per the data published in February 2022 by the Heart and Stroke Foundation Canada, around 750,000 people were living with heart failure, and 100,000 people were diagnosed with this incurable condition each year, which is further expected to increase with the rising aging population and cardiovascular risk factors such as hypertension and smoking, among others. Therefore, there is a growing need for better dietary inclusions in the lives of Canadian people, which is expected to boost the demand for clinical nutrition products in the coming years.
Furthermore, metabolic diseases are one of the key applications of clinical nutrition products. The increasing incidence of diseases such as diabetes in compliance with the rising investment from the Canadian government for diabetes research and development is propelling the growth of the studied market in the country. For instance, as per the Diabetes Canada Report published in February 2022, over 5,719,000 people were suffering from Diabetes in Canada as of 2022, which is expected to reach 7,277,000 by the year 2032. To cope with the rising burden of diabetes, people are inclining more toward dietary changes and adopting clinical nutrition, which is a beneficial factor for the market studied.
Canada's rapidly aging population presents a significant opportunity for the clinical nutrition market. For instance, the Toronto Star newspaper published in February 2023 stated that 1 in 4 Canadians will be older than 65 by 2035. Additionally, seniors account for almost 445 of provincial and territorial healthcare budgets, and unpaid care provision costs Canada an estimated USD 1.3 billion in productivity losses each year. Thus, as the demand for senior care rises, the need for specialized nutritional products and services to address the unique needs of the elderly will continue to grow in the market in the forecast period.
Hence, owing to the above-mentioned factors, such as the growing burden of chronic and metabolic diseases, the growing cases of diabetics, and the rising older population in the country, the market studied is believed to witness significant growth during the forecast period.
However, stringent regulatory policies are expected to hinder market growth in the long run.
Canada Clinical Nutrition Market Trends
Malnutrition is Expected to Hold a Major Share in the Coming Years
Malnutrition is one of the biggest challenges that Canada faces in some territories. The presence of organizations such as the Canadian Malnutrition Task Force (CMTF) in the country significantly benefits the clinical nutrition market as these organizations help the general population understand the significance of nutrition in daily life.
The number of people with malnutrition is rising in the country, which is propelling the demand for clinical nutrition. For instance, as per the data from Statistics Canada published in February 2023, it was indicated that over 6.9 million people in around ten provinces of Canada lived in food-insecured households, which included over 1.8 million children. The Canadian government is providing funds to cope with the rising food insecurity, which results in malnutrition. For instance, in May 2023, the Canadian government announced funding of USD 84.6 million to fight against malnutrition in Canada and globally.
Canada's regulatory authorities are focusing on funding several clinics to develop personalized nutrition products. For instance, in January 2022, the National Institutes of Health (NIH) provided funding of USD 170 million. They announced that it would be utilized nationwide for the next five years in clinics and centers. The funding was majorly provided for a new study to predict individual responses to food and dietary routines. Therefore, with such funding for nutrition improvement across the country, the segment is expected to witness significant growth during the study period.
Pediatric Clinical Nutrition is Expected to Witness a Strong Growth in Coming Years
The pediatric nutrition segment of the market studied is expected to grow due to factors such as growing pre-term births and companies' rising focus on launching new products in the market.
The companies operating in Canada are implementing various growth strategies, including acquisitions, new product launches, and partnerships, to expand their product portfolio and geographical presence in the market. For instance, in February 2022, Nestle Health Science signed an acquisition of Orgain Company, a plant-based nutrition product company. With the help of this acquisition, Nestle expanded the reach of plant-based nutrition products. Hence, companies' initiatives to launch products in the Canadian market are expected to grow significantly during the forecast period.
Canada Clinical Nutrition Industry Overview
The market for clinical nutrition in Canada is moderately competitive and fragmented in nature. The market players are continuously engaged in expanding their presence through various inorganic growth strategies, such as acquisition, merger, and strategic collaboration, to gain significant market share and strengthen their product portfolios. Some of the key players in the market include Abbott Laboratories, Nestle SA, Baxter Healthcare, B. Braun SE, and Danone, among others.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic and Metabolic Diseases
4.2.2 Increasing Pre-term Births
4.2.3 Rise in the Geriatric Population
4.3 Market Restraints
4.3.1 Stringent Regulation for Clinical Nutrition
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Route of Administration
5.1.1 Oral and Enteral
5.1.2 Parenteral
5.2 By Application
5.2.1 Cancer
5.2.2 Malnutrition
5.2.3 Metabolic Disorders
5.2.4 Neurological Diseases
5.2.5 Gastrointestinal Disorders
5.2.6 Others
5.3 By End User
5.3.1 Pediatric
5.3.2 Adult
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Nestle Health Science
6.1.3 Baxter
6.1.4 B. Braun SE
6.1.5 Danone
6.1.6 Perrigo Company
6.1.7 Fresenius Kabi
6.1.8 Aymes International Ltd
6.1.9 Reckitt Benckiser
6.1.10 Medifood International Ltd
6.1.11 Ajinomoto Cambrook Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic and Metabolic Diseases
4.2.2 Increasing Pre-term Births
4.2.3 Rise in the Geriatric Population
4.3 Market Restraints
4.3.1 Stringent Regulation for Clinical Nutrition
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Route of Administration
5.1.1 Oral and Enteral
5.1.2 Parenteral
5.2 By Application
5.2.1 Cancer
5.2.2 Malnutrition
5.2.3 Metabolic Disorders
5.2.4 Neurological Diseases
5.2.5 Gastrointestinal Disorders
5.2.6 Others
5.3 By End User
5.3.1 Pediatric
5.3.2 Adult
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Nestle Health Science
6.1.3 Baxter
6.1.4 B. Braun SE
6.1.5 Danone
6.1.6 Perrigo Company
6.1.7 Fresenius Kabi
6.1.8 Aymes International Ltd
6.1.9 Reckitt Benckiser
6.1.10 Medifood International Ltd
6.1.11 Ajinomoto Cambrook Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
